Published :
Tables : 50
Figures : 44
Category : Healthcare
No. of Pages : 229
Report Code : HC-U5539
North America IVD Market is poised to value over USD 35.2 billion by 2027 end at a CAGR of over 4.5% during the forecast period 2020 to 2027. FutureWise Market Research has instantiated a report that provides an intricate analysis of North America IVD Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the North America IVD Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the North America IVD Market: • Abbott Laboratories • Johnson and Johnson • Siemens Healthineers • Becton Dickinson and Company • F.Hoffmann-La Roche (Roche) • Beckman Coulter • BioMerieux S.A. • Ortho Clinical Dignostics, Inc • Bio-Rad Laboratories • Danaher Corporation • Sysmex Corporation • Thermo Fisher Scientific Inc. • Qiagen N.V. (Note: The list of the major players will be updated with the latest market scenario and trends) North America IVD Market Segmentation: By Product • Instruments • Kits • Reagents • Software By Technology • Clinical Chemistry • Hematology • Immunoassay • Coagulation and Hemostasis • Molecular Diagnostics • Microbiology • Other IVD Technology By Applications • Diabetes • Infectious Disease • Oncology/Cancer • Cardiology • Nephrology • Autoimmune Disease • Drug Testing • HIV By Region • U.S.A • Canada • Mexico Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the North America IVD Market By Product, By Technology, By Applications and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— U.S.A, Canada, Mexico. • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of North America IVD Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the North America IVD Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the North America IVD Market: • Abbott Laboratories • Johnson and Johnson • Siemens Healthineers • Becton Dickinson and Company • F.Hoffmann-La Roche (Roche) • Beckman Coulter • BioMerieux S.A. • Ortho Clinical Dignostics, Inc • Bio-Rad Laboratories • Danaher Corporation • Sysmex Corporation • Thermo Fisher Scientific Inc. • Qiagen N.V. (Note: The list of the major players will be updated with the latest market scenario and trends)
North America IVD Market Segmentation: By Product • Instruments • Kits • Reagents • Software
By Technology • Clinical Chemistry • Hematology • Immunoassay • Coagulation and Hemostasis • Molecular Diagnostics • Microbiology • Other IVD Technology By Applications • Diabetes • Infectious Disease • Oncology/Cancer • Cardiology • Nephrology • Autoimmune Disease • Drug Testing • HIV
By Region • U.S.A • Canada • Mexico
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the North America IVD Market By Product, By Technology, By Applications and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— U.S.A, Canada, Mexico. • To record and evaluate competitive landscape mapping- Type launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. North America IVD Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of North America IVD Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. North America IVD Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. North America IVD Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Instruments 7.2. Kits 7.3. Reagents 7.4. Software 8. North America IVD Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Clinical Chemistry 8.2. Hematology 8.3. Immunoassay 8.4. Coagulation and Hemostasis 8.5. Molecular Diagnostics 8.6. Microbiology 8.7. Other IVD Technology 9. North America IVD Market, By Applications Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Diabetes 9.2. Infectious Disease 9.3. Oncology/Cancer 9.4. Cardiology 9.5. Nephrology 9.6. Autoimmune Disease 9.7. Drug Testing 9.8. HIV 10. North America IVD Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Market Share Analysis and Competitive Landscape 11.1. North America Landscape - Key Players, Revenue and Presence 11.2. North America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 11.3. North America Emerging Companies 11.4. North America - Market Share Analysis and Key Regional Players 11.7. North America Key Player - Growth Matrix 12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 12.1. Abbott Laboratories 12.1.1. Company Overview 12.1.2. Product Portfolio 12.1.3. SWOT Analysis 12.1.4. Financial Overview 12.1.5. Strategic Overview 12.2. Johnson and Johnson 12.2.1. Company Overview 12.2.2. Product Portfolio 12.2.3. SWOT Analysis 12.2.4. Financial Overview 12.2.5. Strategic Overview 12.3. Siemens Healthineers 12.3.1. Company Overview 12.3.2. Product Portfolio 12.3.3. SWOT Analysis 12.3.4. Financial Overview 12.3.5. Strategic Overview 12.4. Becton Dickinson and Company 12.4.1. Company Overview 12.4.2. Product Portfolio 12.4.3. SWOT Analysis 12.4.4. Financial Overview 12.4.5. Strategic Overview 12.5. F.Hoffmann-La Roche (Roche) 12.5.1. Company Overview 12.5.2. Product Portfolio 12.5.3. SWOT Analysis 12.5.4. Financial Overview 12.5.5. Strategic Overview 12.6. Beckman Coulter 12.6.1. Company Overview 12.6.2. Product Portfolio 12.6.3. SWOT Analysis 12.6.4. Financial Overview 12.6.5. Strategic Overview 12.7. BioMerieux S.A. 12.7.1. Company Overview 12.7.2. Product Portfolio 12.7.3. SWOT Analysis 12.7.4. Financial Overview 12.7.5. Strategic Overview 12.8. Ortho Clinical Dignostics, Inc 12.8.1. Company Overview 12.8.2. Product Portfolio 12.8.3. SWOT Analysis 12.8.4. Financial Overview 12.8.5. Strategic Overview 12.9. Bio-Rad Laboratories. 12.9.1. Company Overview 12.9.2. Product Portfolio 12.9.3. SWOT Analysis 12.9.4. Financial Overview 12.9.5. Strategic Overview 12.10.Danaher Corporation 12.10.1. Company Overview 12.10.2. Product Portfolio 12.10.3. SWOT Analysis 12.10.4. Financial Overview 12.10.5. Strategic Overview 12.11.Sysmex Corporation 12.11.1. Company Overview 12.11.2. Product Portfolio 12.11.3. SWOT Analysis 12.11.4. Financial Overview 12.11.5. Strategic Overview 12.12.Thermo Fisher Scientific Inc. 12.12.1. Company Overview 12.12.2. Product Portfolio 12.12.3. SWOT Analysis 12.12.4. Financial Overview 12.12.5. Strategic Overview 12.13.Qiagen N.V. 12.13.1. Company Overview 12.13.2. Product Portfolio 12.13.3. SWOT Analysis 12.13.4. Financial Overview 12.13.5. Strategic Overview 13. Pre and Post COVID-19 Impact 13.1. Positive influence on the healthcare industry 13.2. The financial disruption of the manufacturing sector 13.3. Impact of COVID-19 on emerging companies 13.4. Significant mandates in the healthcare regulations initiated by administrations 13.5. The overall economic slowdown of the developing and developed nations 14. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. North America IVD Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of North America IVD Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. North America IVD Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. North America IVD Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Instruments 7.2. Kits 7.3. Reagents 7.4. Software 8. North America IVD Market, By Technology Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Clinical Chemistry 8.2. Hematology 8.3. Immunoassay 8.4. Coagulation and Hemostasis 8.5. Molecular Diagnostics 8.6. Microbiology 8.7. Other IVD Technology 9. North America IVD Market, By Applications Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Diabetes 9.2. Infectious Disease 9.3. Oncology/Cancer 9.4. Cardiology 9.5. Nephrology 9.6. Autoimmune Disease 9.7. Drug Testing 9.8. HIV 10. North America IVD Market Analysis 2016–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Market Share Analysis and Competitive Landscape 11.1. North America Landscape - Key Players, Revenue and Presence 11.2. North America Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 11.3. North America Emerging Companies 11.4. North America - Market Share Analysis and Key Regional Players 11.7. North America Key Player - Growth Matrix
12. Company Profiles (Competition Dashboard, Competitors Deep Dive, Types Offered and Financial Layouts) 12.1. Abbott Laboratories 12.1.1. Company Overview 12.1.2. Product Portfolio 12.1.3. SWOT Analysis 12.1.4. Financial Overview 12.1.5. Strategic Overview 12.2. Johnson and Johnson 12.2.1. Company Overview 12.2.2. Product Portfolio 12.2.3. SWOT Analysis 12.2.4. Financial Overview 12.2.5. Strategic Overview 12.3. Siemens Healthineers 12.3.1. Company Overview 12.3.2. Product Portfolio 12.3.3. SWOT Analysis 12.3.4. Financial Overview 12.3.5. Strategic Overview 12.4. Becton Dickinson and Company 12.4.1. Company Overview 12.4.2. Product Portfolio 12.4.3. SWOT Analysis 12.4.4. Financial Overview 12.4.5. Strategic Overview 12.5. F.Hoffmann-La Roche (Roche) 12.5.1. Company Overview 12.5.2. Product Portfolio 12.5.3. SWOT Analysis 12.5.4. Financial Overview 12.5.5. Strategic Overview 12.6. Beckman Coulter 12.6.1. Company Overview 12.6.2. Product Portfolio 12.6.3. SWOT Analysis 12.6.4. Financial Overview 12.6.5. Strategic Overview 12.7. BioMerieux S.A. 12.7.1. Company Overview 12.7.2. Product Portfolio 12.7.3. SWOT Analysis 12.7.4. Financial Overview 12.7.5. Strategic Overview 12.8. Ortho Clinical Dignostics, Inc 12.8.1. Company Overview 12.8.2. Product Portfolio 12.8.3. SWOT Analysis 12.8.4. Financial Overview 12.8.5. Strategic Overview 12.9. Bio-Rad Laboratories. 12.9.1. Company Overview 12.9.2. Product Portfolio 12.9.3. SWOT Analysis 12.9.4. Financial Overview 12.9.5. Strategic Overview 12.10.Danaher Corporation 12.10.1. Company Overview 12.10.2. Product Portfolio 12.10.3. SWOT Analysis 12.10.4. Financial Overview 12.10.5. Strategic Overview 12.11.Sysmex Corporation 12.11.1. Company Overview 12.11.2. Product Portfolio 12.11.3. SWOT Analysis 12.11.4. Financial Overview 12.11.5. Strategic Overview 12.12.Thermo Fisher Scientific Inc. 12.12.1. Company Overview 12.12.2. Product Portfolio 12.12.3. SWOT Analysis 12.12.4. Financial Overview 12.12.5. Strategic Overview 12.13.Qiagen N.V. 12.13.1. Company Overview 12.13.2. Product Portfolio 12.13.3. SWOT Analysis 12.13.4. Financial Overview 12.13.5. Strategic Overview 13. Pre and Post COVID-19 Impact 13.1. Positive influence on the healthcare industry 13.2. The financial disruption of the manufacturing sector 13.3. Impact of COVID-19 on emerging companies 13.4. Significant mandates in the healthcare regulations initiated by administrations 13.5. The overall economic slowdown of the developing and developed nations
14. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics